Navigation Links
ClinStar to Present on Clinical Trial Recruitment in the Emerging Regions of Russia and Eastern Europe

SAN FRANCISCO, Oct. 18, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today that President and CEO David Passov and Manager of Clinical Operations Alexander Kutermin will speak at Global Engage's 3rd Oncology Clinical Trials in Emerging Regions conference, November 3-4, in Philadelphia, PA.  


According to the International Agency for Research on Cancer's (a division of the World Health Organization) GLOBOCAN 2008 report, an estimated 12.7 million people worldwide are diagnosed with some form of cancer annually and this number is expected to jump to 21 million by 2030. The emerging markets of Russia, Ukraine, Belarus and the Baltics offer access to a population of more than five million cancer sufferers. By conducting clinical trials in these regions, biopharmaceutical companies can significantly speed enrollment, and thereby, reduce the overall time and cost to develop an oncology drug.  

During the presentation scheduled for Friday, November 4 at 1:30 p.m., Mr. Passov will explore perceptions and comparisons of emerging markets and discuss how to navigate cultural and regulatory challenges in the region in order to optimize recruitment. Mr. Kutermin will present a case study revealing how Russia, Ukraine, Belarus and the Baltics outperformed 20+ other countries in a global, Phase III breast cancer trial.  

Through a series of keynote regional presentations, case studies and interactive panel discussions, Global Engage's 3rd Oncology Clinical Trials in Emerging Regions conference will examine the current role that emerging regions play in conducting oncology clinical trials with a focus on the operational, regulatory and logistical challenges involved.  

About ClinStar, LLC

ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ClinStar to Present on Russias Performance as an Emerging Market in Global Clinical Trials
2. ClinStar to Present on Conducting Clinical Trials in Russia
3. ClinStar, LLC Establishes New Office on the US East Coast
4. Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress
5. Renessa® Treatment for Stress Incontinence: Three Year Clinical Results Presented
6. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
7. Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)
8. PLC Medical Systems CEO Presentation Now Available for On-demand Viewing at
9. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
10. Ziehm Imaging Presents new 20 kW Ziehm Vision R
11. Amerigroup Foundation Presents Grant to Rx Partnership in Virginia
Post Your Comments:
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):